The Cancer/Tumor Profiling Market is poised for significant growth, projected to reach $24.70 billion by 2031, reflecting a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031. This growth trajectory underscores a fundamental shift in oncology driven by an increase in cancer diagnoses and the urgent need for personalized treatment solutions that can effectively meet the complexities...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian